SILO Pharma Inc’s filing revealed that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $2075.0 on Dec 15 ’25. In the deal valued at $0.41 per share,5,000 shares were bought. As a result of this transaction, Weisblum Eric now holds 216,932 shares worth roughly $75926.2.
Then, Weisblum Eric bought 1,000 shares, generating $370 in total proceeds. Upon buying the shares at $0.37, the Chief Executive Officer now owns 210,932 shares.
Before that, Weisblum Eric bought 1,000 shares. SILO Pharma Inc shares valued at $365 were divested by the Chief Executive Officer at a price of $0.36 per share. As a result of the transaction, Weisblum Eric now holds 211,932 shares, worth roughly $74176.2.
Price Performance Review of SILO
On Tuesday, SILO Pharma Inc [NASDAQ:SILO] saw its stock jump 4.67% to $0.35. Over the last five days, the stock has lost -18.60%. SILO Pharma Inc shares have fallen nearly -63.20% since the year began. Nevertheless, the stocks have fallen -60.67% over the past one year. While a 52-week high of $3.37 was reached on 01/08/25, a 52-week low of $0.33 was recorded on 12/30/25.
Levels Of Support And Resistance For SILO Stock
The 24-hour chart illustrates a support level at 0.3320, which if violated will result in even more drops to 0.3139. On the upside, there is a resistance level at 0.3612. A further resistance level may holdings at 0.3723.
How much short interest is there in SILO Pharma Inc?
A steep rise in short interest was recorded in SILO Pharma Inc stocks on 2025-12-15, dropping by 62607.0 shares to a total of 0.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.57 million shares. There was a decline of -12.42%, which implies that there is a negative sentiment for the stock.
